Nataly Tarasenko
Impact in
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
Papers in
-
- Histone Deacetylase Inhibitors Research 14
- Protein Degradation and Inhibitors 4
- Epigenetics and DNA Methylation 3
- Signaling Pathways in Disease 2
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Cancer Cells and Metastasis 2
- Co-authors
- Ada Rephaeli (18 shared papers)Abraham Nudelman (17 shared papers)Suzanne M. Cutts (7 shared papers)Don R. Phillips (6 shared papers)Michal Entin‐Meer (3 shared papers)Gania Kessler‐Icekson (5 shared papers)Aida Inbal (3 shared papers)Zvi Malik (3 shared papers)
- Journals
- Investigational New Drugs (4 papers)European Journal of Pharmaceutical Sciences (2 papers)Cancer Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- IsraelAustraliaUnited States
In The Last Decade
Nataly Tarasenko
22 papers receiving 373 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 258
- Geriatrics and Gerontology 12
- Oncology 81
- Physiology 13
- Biological Psychiatry 6
Countries citing papers authored by Nataly Tarasenko
This map shows the geographic impact of Nataly Tarasenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataly Tarasenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataly Tarasenko more than expected).
Fields of papers citing papers by Nataly Tarasenko
This network shows the impact of papers produced by Nataly Tarasenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataly Tarasenko. The network helps show where Nataly Tarasenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Nataly Tarasenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 39 | |
| 2 | 2005 | 37 | |
| 3 | 2006 | 36 | |
| 4 | 2008 | 35 | |
| 5 | 2010 | 33 | |
| 6 | 2007 | 31 | |
| 7 | 2012 | 21 | |
| 8 | 2007 | 20 | |
| 9 | 2014 | 18 | |
| 10 | 2012 | 16 | |
| 11 | 2017 | 15 | |
| 12 | 2009 | 14 | |
| 13 | 2017 | 14 | |
| 14 | 2016 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2017 | 10 | |
| 17 | 2022 | 6 | |
| 18 | 2016 | 4 | |
| 19 | 2022 | 2 | |
| 20 | Changes in the M1 of hybrid gladioli caused by gamma irradiation. | 1980 | 1 |
About Nataly Tarasenko
Nataly Tarasenko is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 376 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (14 papers), Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (4 papers), Epigenetics and DNA Methylation (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Signaling Pathways in Disease (2 papers), Cancer Cells and Metastasis (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Molecular Biology (258 citations), Geriatrics and Gerontology (12 citations), Oncology (81 citations), Physiology (13 citations) and Biological Psychiatry (6 citations). Nataly Tarasenko has collaborated with scholars based in Israel, Australia and United States. Frequent co-authors include Ada Rephaeli, Abraham Nudelman, Suzanne M. Cutts, Don R. Phillips, Michal Entin‐Meer, Gania Kessler‐Icekson, Aida Inbal, Zvi Malik, Daphne A. Haas‐Kogan and P. Boer. Their work appears in journals such as Investigational New Drugs, European Journal of Pharmaceutical Sciences, Cancer Letters, Journal of Medicinal Chemistry and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.